等待开盘 05-19 09:30:00 美东时间
+1.060
+1.24%
今日重点评级关注:HC Wainwright & Co.:维持Caribou Biosciences"买入"评级,目标价从9美元升至11美元;康托·菲茨杰拉德:维持Artiva Biotherapeutics"超配"评级,目标价从10美元升至40美元
05-12 12:36
今日重点评级关注:HC Wainwright & Co.:维持Artiva Biotherapeutics"买入"评级,目标价从15美元升至35美元;韦德布什:维持Cullinan Therapeutics"跑赢大市"评级,目标价从36美元升至37美元
05-11 15:43
今日重点评级关注:Citizens:维持Avalo Therapeutics"跑赢大市"评级,目标价从52美元升至62美元;BTIG:维持Avalo Therapeutics"买入"评级,目标价从40美元升至58美元
05-07 12:37
PennyMac Financial (PFSI) declares $0.30/share quarterly dividend, in line with previous. Forward yield 1.37% Payable May 28; for shareholders of record May 18; ex-div May 18. See PFSI Dividend Scorec...
05-06 22:23
Wells Fargo analyst Donald Fandetti maintains PennyMac Financial Servs (NYSE:PFSI) with a Overweight and lowers the price target from $110 to $100.
05-06 21:00
华盛资讯5月6日讯,PennyMac金融服务公布2026财年Q1业绩,公司Q1营收5.45亿美元,同比增长26.5%,归母净利润0.82亿美元,同比增长7.9%。
05-06 07:07
华盛资讯5月6日讯,PennyMac金融服务公布2026财年Q1业绩,公司Q1营收5.45亿美元,同比增长26.5%,归母净利润0.82亿美元,同比增长7.9%。
05-06 06:45
Companies Reporting Before The Bell • Repligen (NASDAQ:RGEN) is projected to re...
05-05 19:12
今日重点评级关注:瑞银:维持SS&C科技"买入"评级,目标价从112美元升至115美元;Piper Sandler:维持儒博实业"超配"评级,目标价从530美元升至540美元
04-27 14:04
Stephens & Co. analyst Kyle Joseph initiates coverage on PennyMac Financial Servs (NYSE:PFSI) with a Equal-Weight rating and announces Price Target of $100.
04-24 21:11